- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/38 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
Patent holdings for IPC class C07C 237/38
Total number of patents in this class: 23
10-year publication summary
2
|
1
|
0
|
3
|
0
|
0
|
2
|
2
|
1
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Boehringer Ingelheim International GmbH | 4629 |
3 |
The Regents of the University of California | 18943 |
2 |
Takeda Pharmaceutical Company Limited | 2961 |
2 |
Ishihara Sangyo Kaisha, Ltd. | 663 |
2 |
Milliken & Company | 1253 |
2 |
Novartis AG | 11238 |
1 |
Bristol-myers Squibb Company | 5080 |
1 |
Tsinghua University | 5426 |
1 |
National Institute of Advanced Industrial Science and Technology | 3677 |
1 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 156 |
1 |
Genfit | 257 |
1 |
JE IL Pharmaceutical Co., Ltd. | 49 |
1 |
MethylGene Inc. | 51 |
1 |
Technologie Alpine de Securite - TAS | 22 |
1 |
Sanofi | 3836 |
1 |
Epiodyne, Inc. | 7 |
1 |
Escient Pharmaceuticals, Inc. | 29 |
1 |
Other owners | 0 |